go back

Diphenhydramine, Oral

Louisiana rates for HCPCS Q0163

Diphenhydramine HCl, 50 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at time of chemotherapy treatment not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$40%20%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.1$0.5$2.0$10.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$7.94
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$0.03
Typical High
$0.03
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.03
Median
$0.03
Typical High
$0.03
Christus
Setting
Facility
Modifier
Global
Typical Low
$39.81
Median
$39.81
Typical High
$39.81
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.04
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
United
Setting
Facility
Modifier
Global
Typical Low
$1.17
Median
$1.38
Typical High
$1.70
United
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02